Orexo sues Sun Pharma over opioid dependence generic

Swedish pharmaceutical company Orexo has taken India-based Sun Pharmaceutical to court in the US, over its plans to launch a generic version of Orexo’s opioid dependence treatment.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Fed Circ denies Sun Pharma patent for alopecia treatment

24 August 2023 Indian drugmaker had challenged PTAB decision that patent for new version of ruxolitinib was invalid as obvious | Decision hands a victory to US rival.

Americas

Bausch Health settles with Sun Pharma

23 September 2020 Canada-based Bausch Health has dropped its litigation against Indian generic maker Sun Pharma as part of a settlement agreement.

Americas

Intercept sues Apotex over Ocaliva generic

26 August 2020 Intercept Pharmaceuticals is suing Canadian generics manufacturer Apotex over a proposed version of autoimmune drug Ocaliva.

More on this story

Big Pharma

Fed Circ denies Sun Pharma patent for alopecia treatment

24 August 2023 Indian drugmaker had challenged PTAB decision that patent for new version of ruxolitinib was invalid as obvious | Decision hands a victory to US rival.

Americas

Bausch Health settles with Sun Pharma

23 September 2020 Canada-based Bausch Health has dropped its litigation against Indian generic maker Sun Pharma as part of a settlement agreement.

Americas

Intercept sues Apotex over Ocaliva generic

26 August 2020 Intercept Pharmaceuticals is suing Canadian generics manufacturer Apotex over a proposed version of autoimmune drug Ocaliva.

More on this story

Big Pharma

Fed Circ denies Sun Pharma patent for alopecia treatment

24 August 2023 Indian drugmaker had challenged PTAB decision that patent for new version of ruxolitinib was invalid as obvious | Decision hands a victory to US rival.

Americas

Bausch Health settles with Sun Pharma

23 September 2020 Canada-based Bausch Health has dropped its litigation against Indian generic maker Sun Pharma as part of a settlement agreement.

Americas

Intercept sues Apotex over Ocaliva generic

26 August 2020 Intercept Pharmaceuticals is suing Canadian generics manufacturer Apotex over a proposed version of autoimmune drug Ocaliva.